For Immediate Release
February 22, 2022

Calgary, Alberta – Delta CleanTech Inc. (“Delta” or the “Company”) (CSE:DELT; FRA:66C; OTCQB:DCTIF) is pleased to announce a strategic Technology Licensing Agreement with Carbon RX to facilitate the origination, validation, and tokenization of multiple streams of voluntary and compliance carbon credits utilizing Delta’s decarbonization technology platform.

Carbon RX originates, validates fidelity, certifies, and registers voluntary carbon credits that will incorporate legacy & new industrial processes with technologies which will require Carbon RX’s carbon credit fidelity validation and tokenization platform utilizing block chain technology.

Industries that will benefit from Carbon RX’s carbon credit technologies include: CO2 capture in power generation and energy processing; CO2 capture through blue hydrogen production, cement manufacturing, methane collection and incineration, reclaiming of industrial liquids; and CO2 mitigation in agriculture and forestry.

Carbon RX, Delta’s wholly owned subsidiary, has a rich history going back to 2006 as being Canada’s largest voluntary carbon credit originator, aggregator, and streamer through its C-Green Aggregators and Carbon Methane Management divisions.

Jeff Allison, Delta CleanTech’s President, commented “Voluntary and compliance credits are quickly becoming an inevitable part of the everyday business cycle, as many companies will require voluntary and compliance carbon credits to meet their net-zero corporate objectives. We expect that carbon credit origination and certification will become a substantial business for Delta and Carbon RX. Qualified estimates show that demand could increase 15 times by 2030 to $50 billion.”About Carbon RX Inc.

About Delta CleanTech Inc.
Delta CleanTech Inc. is a 15-year ESG-driven, recognized global technology leader in CO2 Capture, Decarbonization of Energy, Solvent & Glycol Reclamation, Blue Hydrogen Production, and Carbon Credit Aggregation and Management. Delta continues to provide solutions to clients all over the world in sequestering, capturing, and reducing CO2 and through its Carbon RX wholly owned subsidiary is originating, validating, tokenizing, and streaming Carbon Credits.

About Carbon RX
CarbonRX Inc. (“Carbon RX”), was founded in 2006 and is a wholly owned subsidiary of Delta CleanTech Inc. and
an historic North American leader in the origination, validation, and streaming of voluntary Carbon Credits. Carbon
RX is again leading the industry in utilizing its proprietary decarbonization and GHG mitigation technologies to
originate high fidelity Carbon Credits and is leveraging blockchain technology to tokenize and add more security
and higher value to this asset class.

For media inquiries
Jeff Allison, President
Phone: 306‐352-6132
Cell: 306-530-6025
E‐mail: jallison@deltacleantech.ca

Forward Looking Statements
This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation, which is based on Carbon RX’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. All statements other than statements of historical fact are forward-looking information. Forward-looking information can be identified by the use of forward-looking terminology such as “expect”, “likely”, “may”, “might”, “will”, “shall”, “should”, “intend”, “anticipate”, “project”, “contemplate”, “continue”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance, or other statements that are not statements of fact. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. No assurance can be given that these expectations will prove to be correct and such forward-looking information included in this news release should not be unduly relied upon. These statements speak only as of the date of this news release. Carbon RX does not undertake any obligations to publicly update or revise any forward-looking information except as required by securities law.

The CSE does not accept responsibility for the adequacy or accuracy of this release.